会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • AMINATED POLYAMINES
    • 氨基聚氨酯
    • WO2006052229A1
    • 2006-05-18
    • PCT/US2004/036485
    • 2004-11-03
    • UNIVERSITY OF FLORIDABERGERON, Raymond, J., Jr
    • BERGERON, Raymond, J., Jr
    • C07C211/13
    • C07C211/13
    • An aminated polyamine having the formula (I), or its possible stereoisomers or a salt thereof with a pharmaceutically acceptable acid wherein, R 1 and R 4 may be the same or different and are alkyl, aryl, aryl alkyl or cycloalkyl, optionally having an alkyl chain interrupted by at least one etheric oxygen atom; R 2 and R 3 may be the same or different and are R 1 , R 4 or H; N 1 , N 2 , N 3 and N 4 are nitrogen atoms capable of protonation at physiological pH's; ALK 1 , ALK 2 AND ALK 3 may be the same or different and are straight or branched chain alkylene bridging groups having 1 to 4 carbon atoms which effectively maintain the distance between the nitrogen atoms such that the polyamine: (i) is capable of uptake by a target cell upon administration of the polyamine to a human or non-human animal or is capable of binding to at least one polyamine site of a receptor located within or on the surface of a cell upon administration of the polyamine to a human or non-human animal; and (ii) upon uptake by the target cell, competitively binds via an electrostatic interaction between the positively charged nitrogen atoms to biological counter-anions; the polyamine, upon binding to the biological counter-anion in the cell, functions in a manner biologically different than the intracellular polyamines; and further wherein at least one of said bridging groups ALK 1 , ALK 2 and ALK 3 contains at least one -CH(NRH)- group which is not alpha- to either of the nitrogen atoms and R is H, alkyl, acyl or sulfonyl.
    • 具有式(I)的胺化多胺或其可能的立体异构体或其药学上可接受的酸的盐,其中R 1和R 4可以相同或不同 并且是烷基,芳基,芳基烷基或环烷基,任选地具有被至少一个醚氧原子间隔的烷基链; R 2和R 3可以相同或不同,为R 1,R 4或H; N 1,N 2,N 3和N 4是在生理pH下能够质子化的氮原子; ALK 1,ALK 2和AL 3 3可以相同或不同,并且是具有1至4个碳原子的直链或支链亚烷基桥连基团 其有效地保持氮原子之间的距离,使得多胺:(i)在将多胺向人或非人动物施用时能够被靶细胞吸收或能够结合到至少一个多胺位点 将多胺施用于人或非人动物时位于细胞表面内或细胞表面的受体; 和(ii)被靶细胞吸收后,通过带正电的氮原子之间的静电相互作用与生物反阴离子竞争结合; 多胺在与细胞中的生物反阴离子结合时以与细胞内多胺生物学不同的方式起作用; 并且其中所述桥连基团ALK 1,ALK 2和ALK 3 3中的至少一个含有至少一个-CH(NRH) - 基团 其不是氮原子中的任一个,R是H,烷基,酰基或磺酰基。
    • 3. 发明公开
    • AMINATED POLYAMINES
    • 胺化多胺
    • EP1812377A1
    • 2007-08-01
    • EP04800606.8
    • 2004-11-03
    • University of Florida
    • BERGERON, Raymond, J., Jr
    • C07C211/13A61K31/13
    • C07C211/13
    • An aminated polyamine having the formula (I), or its possible stereoisomers or a salt thereof with a pharmaceutically acceptable acid wherein, R1 and R4 may be the same or different and are alkyl, aryl, aryl alkyl or cycloalkyl, optionally having an alkyl chain interrupted by at least one etheric oxygen atom; R2 and R3 may be the same or different and are R1, R4 or H; N1, N2, N3 and N4 are nitrogen atoms capable of protonation at physiological pH's; ALK1, ALK2 AND ALK3 may be the same or different and are straight or branched chain alkylene bridging groups having 1 to 4 carbon atoms which effectively maintain the distance between the nitrogen atoms such that the polyamine: (i) is capable of uptake by a target cell upon administration of the polyamine to a human or non-human animal or is capable of binding to at least one polyamine site of a receptor located within or on the surface of a cell upon administration of the polyamine to a human or non-human animal; and (ii) upon uptake by the target cell, competitively binds via an electrostatic interaction between the positively charged nitrogen atoms to biological counter-anions; the polyamine, upon binding to the biological counter-anion in the cell, functions in a manner biologically different than the intracellular polyamines; and further wherein at least one of said bridging groups ALK1, ALK2 and ALK3 contains at least one -CH(NRH)- group which is not alpha- to either of the nitrogen atoms and R is H, alkyl, acyl or sulfonyl.